Target intelligence / Profile preview

Fc receptor-like protein 2 (FCRL2)

Target
FCRL2
Molecular classification
Receptor, Immunoglobulin superfamily, Fc receptor-like protein
01

Overview

Fc receptor-like protein 2 is a transmembrane glycoprotein member of the immunoglobulin receptor superfamily, predominantly expressed on human B cells, especially memory B cells. It contains four extracellular C2-type immunoglobulin domains, a transmembrane region, and a cytoplasmic domain with one immunoreceptor-tyrosine activation motif (ITAM-like) and two immunoreceptor-tyrosine inhibitory motifs (ITIMs). Upon activation, the ITIMs recruit the tyrosine phosphatase SHP-1, thereby inhibiting B cell receptor-mediated signal transduction. This regulatory function positions FCRL2 as a negative modulator of B cell activation and as a biomarker for less aggressive, mutated forms of chronic lymphocytic leukemia. The endogenous ligand for FCRL2 remains unknown, and its expression is largely restricted to lymphoid tissues such as spleen, lymph node, and tonsil, as well as peripheral blood B cells[1][2][3].

Other names
FcRH2IRTA4CD307bSPAP1Immunoglobulin receptor translocation-associated protein 4SH2 domain-containing phosphatase anchor protein 1Fc receptor homolog 2IFGP4IFGP family protein 4
02

Mechanism of action

Inhibition of B cell receptor (BCR) signaling via recruitment of SHP-1 phosphatase to ITIM motifs, Immunomodulatory effects on B lymphocyte activation

03

Biological functions

Immune responseImmunomodulationRegulation of B cell activationNegative regulation of B cell receptor signaling
04

Disease associations

CancerLeukemia (specifically chronic lymphocytic leukemia)Other B cell malignancies
05

Safety considerations

Target may be broadly expressed on B cells (risk of immune suppression if targeted); specifics not well documented in publicly available sources
06

Biomarkers

Prognostic marker for chronic lymphocytic leukemia

Beyond the preview

Go deeper on Fc receptor-like protein 2 (FCRL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fc receptor-like protein 2 (FCRL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call